Qualitek Labs has announced a board meeting on the approval of a share swap to acquire the remaining 2,54,959 equity shares of Interstellar Testing Centre Private Limited (ITCPL), completing its 100% acquisition.

The company will issue 16,72,531 equity shares at a ratio of 6.56 shares for every ITCPL share.

ITCPL operates in testing and assurance services across pharmaceuticals, food, chemicals, and other sectors, with a turnover of ₹40.58 Cr and net profit of ₹1.94 Cr in FY 2024-25. This acquisition aims to strengthen Qualitek’s testing capabilities and diversify its offerings.

Finalization is subject to shareholder approval.